Avoid common mistakes on your manuscript.
Introduction
These recommendations cover routine quality control (QC) of instrumentation used within a nuclear medicine department. Routine QC testing starts after installation of the instrument, and after acceptance testing, and continues on a regular basis throughout its lifetime. Additional periodic tests may be carried out to provide more in-depth testing. Recommendations for acceptance testing are covered in a separate document. These recommendations must be considered in the light of any national guidelines and legislation, which must be followed. The recommendations cover the types of tests to be performed, and suggested frequencies, but they do not specify the protocols to be followed, which are available from other reference sources quoted.
Acceptance and reference tests
After installation, and before it is put into clinical use, a nuclear medicine instrument must undergo thorough and careful acceptance testing, the aim being to verify that the instrument performs according to its specifications and its clinical purpose. Each instrument is supplied with a set of basic specifications. These have been produced by the manufacturer according to standard test procedures, which should be traceable to standard protocols, such as the NEMA and IEC performance standards [1–4, 11, 17, 30, 37]. By following such standard protocols in the clinical setting, with support from the vendor for supplying phantoms and software where necessary, specifications can be verified and baseline performance data created. Additional tests are usually also needed in order to more thoroughly test individual components of an instrument. These acceptance test results form the reference data for future QC tests, and some may be repeated periodically, such as at half-yearly or yearly intervals, or whenever a major service or component change has been carried out.
Routine tests
Once the instrument has been accepted for clinical use, its performance needs to be tested routinely with simple QC procedures that are sensitive to changes in performance. Tests must be performed by appropriately qualified and trained staff, and detailed local operating procedures should be written for this routine work. All test results must be recorded and monitored for variations, and appropriate actions taken when changes are observed. The QC tests are an important part of the routine work, and sufficient equipment time and staff time must be allocated for routine QC.
Action thresholds, follow-up, record keeping and review, and monitoring
Records of test results should be kept in a log-book or digital record. Immediate review of the QC results is essential, comparing them to the usual values obtained, and to the action thresholds for that test. Action thresholds should be set locally, taking into account the manufacturer’s recommendations, and other professional guidance. Action thresholds should be set to maintain the system within the specification value of a parameter. When action thresholds are reached a decision needs to be made about whether the instrument is fit for use. The QC operating procedure should make clear the actions to be taken when an action threshold is reached or exceeded, and who is responsible for the decision to use the equipment.
The follow-up actions taken when test results are unsatisfactory and solutions to a problem must be recorded. Such a record may assist troubleshooting if a similar problem occurs.
Routine test recommendations and test frequency
Recommendations for basic routine QC tests that should be scheduled and carried out for the main instruments of the nuclear medicine department are presented in Tables 1, 2, 3, 4, 5, 6, 7, 8 and 9. The tables give briefly the purpose of the test, suggested frequency, and a comment. These are not intended to supersede national guidelines or national regulations, which should always be followed. The test frequencies given should be followed and adjusted according to observations of instrument stability and environmental stability (power supply, temperature and humidity). Where the frequency is indicated as a dual time period, e.g. weekly/monthly, it is recommended that tests are carried out at the shorter time period, and that the test frequency is only reduced if regular testing gives evidence that the system is stable. There is also a note in the legend to each table giving the general type of technology that the recommendations apply to. Specific systems may employ technologies that need other checks, as specified by the manufacturer.
It is a principle of radiation safety and patient protection to ensure that before the administration of a radiopharmaceutical there is suitable equipment to complete the procedure, and that the equipment is functioning correctly. The correct basic function of the device must always be checked after any engineering intervention for repair or calibration, and appropriate engineer’s checks may satisfy this need.
Note: The clocks within the department, within all instruments and all computers must be synchronized and checked daily/at least weekly. This is an essential requirement for accurate activity administration and quantitative data analysis.
Procedures and references
Test procedures are not included in this document, but can be found by reference to standard descriptions (e.g. [1–4]) and national and international protocols. Any manufacturer-supplied test procedures, test phantoms and software should also be taken into account when writing local operating procedures. Some essential literature references are given. They should be consulted for detailed generic test procedures and advice regarding test evaluation, action thresholds and follow-up. It is recommended that each department create detailed written routine QC test procedures specific for each instrument in use. By following standard QC procedures, consistency in test results can be assured and trends monitored.
References
National Electrical Manufacturers Association. NEMA NU 1. Performance measurement of scintillation cameras. Rosslyn, VA: National Electrical Manufacturers Association; 2001, 2007.
International Electrotechnical Commission. IEC 60789. Medical electrical equipment – Characteristics and test conditions of radionuclide imaging devices – Anger type gamma cameras. Geneva: International Electrotechnical Commission; 2005.
International Electrotechnical Commission. IEC 61675-2. Radionuclide imaging devices – Characteristics and test conditions – Part 2: Single photon emission computed tomographs. Consolidated Edition 1.1. Geneva: International Electrotechnical Commission; 2005.
International Electrotechnical Commission. IEC 61675-3. Radionuclide imaging devices – Characteristics and test conditions – Part 3: Gamma camera based whole body imaging systems. Ed 1. Geneva: International Electrotechnical Commission; 1998.
Deutsches Institut für Normung. DIN 6855-2:2005-01. Quality control of nuclear medicine instruments. Part 2: Constancy testing of single crystal gamma-cameras used in planar scintigraphy and in Anger type gamma cameras with rotating detector heads used in single photon emission tomography. Berlin: Deutsches Institut für Normung.
International Atomic Energy Agency. Quality assurance for SPECT systems. Human Health Series No. 6. Vienna: International Atomic Energy Agency; 2009. http://www-pub.iaea.org/MTCD/publications/PDF/Pub1394_web.pdf. Accessed 15 Dec 2009.
International Atomic Energy Agency. Quality control atlas for scintillation camera systems. ISBN 92-0-101303-5. Vienna: International Atomic Energy Agency; 2003. http://www-pub.iaea.org/MTCD/publications/PDF/Pub1141_web.pdf (low resolution images). Accessed 15 Dec 2009.
Hines H, Kayayan R, Colsher J, Hashimoto D, Schubert R, Fernando J, et al. Recommendations for implementing SPECT instrumentation quality control. Nuclear Medicine Section – National Electrical Manufacturers Association (NEMA). Eur Nucl Med 1999;26(5):527–32.
Busemann-Sokole E. Measurement of collimator hole angulation and camera head tilt for slant and parallel hole collimators used in SPECT. J Nucl Med 1987;28:1592–8.
Blokland JA, Camps JA, Pauwels EK. Aspects of performance assessment of whole body imaging systems. Eur J Nucl Med 1997;24(10):1273–83.
National Electrical Manufacturers Association. NEMA NU 2. Performance measurements of positron emission tomographs. Rosslyn, VA: National Electrical Manufacturers Association; 1994, 2001, 2007.
Turkington TG. Introduction to PET instrumentation. J Nucl Med Technol 2001;29:4–11.
Fahey FH. Data acquisition in PET imaging. J Nucl Med Technol 2002;30:39–49.
Daube-Witherspoon ME, Karp JS, Casey ME, DiFilippo FP, Hines H, Muehllehner G, et al. PET performance measurements using the NEMA NU 2-2001 standard. J Nucl Med 2002;43(10):1398–409.
von Schulthess GK. Positron emission tomography versus positron emission tomography/computed tomography: from “unclear” to “new-clear” medicine. Mol Imaging Biol 2004;6(4):183–7.
International Electrotechnical Commission. IEC/TR 61948. Nuclear medicine instrumentation – Routine tests – Part 3: Positron emission tomographs. Geneva: International Electrotechnical Commission; 2005.
Bergmann H, Dobrozemsky G, Minear G, Nicoletti R, Samal M. An inter-laboratory comparison study of image quality of PET scanners using the NEMA NU-2 2001 procedure for assessment of image quality. Phys Med Biol 2005;50:2193–207.
Zanzonico P. Routine quality control of clinical nuclear medicine instrumentation: a brief review. J Nucl Med 2008;49(7):1114–31.
International Atomic Energy Agency. Quality assurance for PET and PET/CT systems. Human Health Series, No. 1. Vienna: International Atomic Energy Agency; 2009. http://www-pub.iaea.org/MTCD/publications/PDF/Pub1393_web.pdf. Accessed 15 Dec 2009.
Lin PJP, Beck TJ, Borras C, et al. Specification and acceptance testing of computed tomography scanners. New York: American Association of Physicists in Medicine; 1993.
Shepard SJ, Lin PJP, Boone JM, et al. Quality control in diagnostic radiology. College Park: American Association of Physicists in Medicine; 2002. p. 1–74.
American College of Radiology. Technical standard for medical nuclear physics performance monitoring of PET-CT imaging equipment. Reston, VA: American College of Radiology. http://www.acr.org/SecondaryMainMenuCategories/quality_safety/guidelines/med_phys/pet_ct_equipment.aspx. Accessed 15 Dec 2009.
International Atomic Energy Agency. Quality assurance for radioactivity measurement in nuclear medicine (appendix VII), Technical Report Series No. 454. Vienna: International Atomic Energy Agency; 2006. http://www-pub.iaea.org/MTCD/publications/PDF/TRS454_web.pdf. Accessed 15 Dec 2009.
International Electrotechnical Commission. IEC/TR 61948 series. Nuclear medicine instrumentation – Routine tests – Part 4: Radionuclide calibrators (IEC 2006-11). Geneva: International Electrotechnical Commission.
Deutsches Institut für Normung. DIN 6855-11:2009-05. Constancy testing of nuclear medicine measuring systems – part 11: Radionuclide calibrators (IEC/TR 61948-4:2006, modified). Berlin: Deutsches Institut für Normung.
Gadd R, Baker M, Nijran KS, Owens S, Thomas W, Woods MJ, et al. Protocol for establishing and maintaining the calibration of medical radionuclide calibrators and their quality control. Measurement Good Practice Guide No. 93. Teddington, UK: National Physical Laboratory; 2006. http://resource.npl.co.uk/cgi-bin/download.pl?area=npl_publications&path_name=/npl_web/pdf/mgpg93.pdf. Accessed 15 Dec 2009
International Atomic Energy Agency. Quality control of nuclear medicine instruments 1991. Technical document 602. Vienna: International Atomic Energy Agency; 1991. http://www-pub.iaea.org/MTCD/publications/PDF/te_602_web.pdf). Accessed 15 Dec 2009.
International Atomic Energy Agency. Quality control of nuclear medicine instruments. Technical document 317. Vienna: International Atomic Energy Agency; 1984. http://www-pub.iaea.org/MTCD/publications/PDF/te_317_prn.pdf. Accessed 15 Dec 2009.
Deutsches Institut für Normung. DIN 6855-1: 2009-07. Constancy testing of nuclear medicine measuring systems – Part 1: Radiation counting systems for measurements in vivo and in vitro (IEC/TR 61948–1:2001, modified). Berlin: Deutsches Institut für Normung.
National Electrical Manufacturers Association. NEMA NU 3. Performance measurements and quality control guidelines for non-imaging intraoperative gamma probes, Rosslyn, VA: National Electrical Manufacturers Association; 2004.
Zanzonico P, Heller S. The intraoperative gamma probe: basic principles and choices available. Semin Nucl Med 2000;30(1):33–48.
Halkar RK, Aarsvold JN. Intraoperative probes. J Nucl Med Technol 1999;27(3):188–93.
Britten AJ. A method to evaluate intra-operative gamma probes for sentinel lymph node localisation. Eur J Nucl Med 1999;26(2):76–83.
Perkins AC, Britten AJ. Specification and performance of intra-operative gamma probes for sentinel node detection. Nucl Med Commun 1999;20(4):309–15.
Tiourina T, Arends B, Huysmans D, Rutten H, Lemaire B, Muller S. Evaluation of surgical gamma probes for radioguided sentinel node localization. Eur J Nucl Med 1998;25(9):1224–31.
Cherry SR, Sorensen JA, Phelps ME. Physics in nuclear medicine. 3rd ed. Philadelphia: Saunders/Elsevier Science; 2003. ISBN 0-7216-8341-X.
National Electrical Manufacturers Association. NEMA NU 4. Performance measurement of small animal positron emission tomographs. Rosslyn, VA: National Electrical Manufacturers Association; 2008.
International Electrotechnical Commission. IEC 61223-1. Evaluation and routine testing in medical imaging departments – Part 1: General aspects. Geneva: International Electrotechnical Commission; 1993.
Bergmann H, Minear G, Raith M, Schaffarich PM. Multiple window spatial registration error of a gamma camera: 133Ba point source as a replacement of the NEMA procedure. BMC Med Phys 2008;8:6.
Kwang K, Lee B, Choe J. SU-FF-I-79: development of the practical guidelines of PET-CT quality control. Med Phys 2009;36:2452.
ImPACT Information Leaflet No. 1: CT Scanner Acceptance Testing, Version 1.02, 18/05/01, http://www.impactscan.org/reports.htm.
Acknowledgments
The authors wish to thank the other members of the EANM Physics Committee for their constructive input: M. Nowak Lonsdale, T. Beyer, B. Sattler, A. Del Guerra, and R. Boellaard. The EANM Physics Committee also wishes to acknowledge all those who participated in the Questionnaire on Quality Control Practice in Europe for Nuclear Medicine Instrumentation (February 2008).
The comments during the review process from the EANM Dosimetry Committee, and the following individuals are appreciated: A.J. Arends (The Netherlands), M. Brambilla (Italy), B. Cari (Spain), S. Christofides (Cyprus), S. Fanti (Italy), B. Farman (France), A. Frenkel (Israel), J. Holzmannhofer (Austria), L. Jødal (Denmark), W. Langsteger (Austria), J. McCavana (Republic of Ireland), O. Mundler (France), F. Pons (Spain), A. Savi (Italy), S.-Å. Starck (Sweden), A. Torresin (Italy; on behalf of EFOMP), P. Trindev (Bulgaria), J. Varga (Hungary).
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
On behalf of the EANM Physics Committee:., Busemann Sokole, E., Płachcínska, A. et al. Routine quality control recommendations for nuclear medicine instrumentation. Eur J Nucl Med Mol Imaging 37, 662–671 (2010). https://doi.org/10.1007/s00259-009-1347-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-009-1347-y